A5052441941- Colorectal Cancer Screening and Detection
- Global Cancer Incidence and Screening
- Gastric Cancer Management and Outcomes
- Genetic factors in colorectal cancer
- Colorectal Cancer Surgical Treatments
- Prostate Cancer Diagnosis and Treatment
- Cervical Cancer and HPV Research
- Colorectal and Anal Carcinomas
- Health Promotion and Cardiovascular Prevention
- Pediatric Urology and Nephrology Studies
- Helicobacter pylori-related gastroenterology studies
- Diverticular Disease and Complications
- Primary Care and Health Outcomes
- Colorectal Cancer Treatments and Studies
- Public Health Policies and Education
- Prostate Cancer Treatment and Research
- Esophageal Cancer Research and Treatment
- Chronic Kidney Disease and Diabetes
- Gastroesophageal reflux and treatments
- Disaster Response and Management
- Economic and Financial Impacts of Cancer
- Cardiovascular Health and Risk Factors
- Mycobacterium research and diagnosis
- BRCA gene mutations in cancer
- Potassium and Related Disorders
Centers for Disease Control and Prevention
2012-2024
National Center for Chronic Disease Prevention and Health Promotion
2010-2024
Emory University
2012
Icahn School of Medicine at Mount Sinai
2007
Sir Charles Gairdner Hospital
2004-2006
National University of Singapore
2006
National University Hospital
2006
The Royal Melbourne Hospital
2004
Wellington Hospital
2004
Peter MacCallum Cancer Centre
2004
BACKGROUND In 2014, a national campaign was launched to increase colorectal cancer (CRC) screening rates in the United States 80% by 2018; it is unknown whether there sufficient colonoscopy capacity reach this goal. This study estimated number of colonoscopies needed screen eligible population with fecal immunochemical testing (FIT) or and determined meet need. METHODS The Microsimulation Screening Analysis–Colon model used simulate CRC test use (2014‐2040); implementation program 2014 FIT...
Colorectal cancer (CRC) is the second leading cause of death in United States cancers that affect both men and women. Despite strong evidence screening for CRC reduces incidence mortality, prevalence below national target. This report describes current by age, various demographic factors, state.Data from 2018 Behavioral Risk Factor Surveillance System survey were analyzed to estimate percentages adults aged 50-75 years who reported consistent with Preventive Services Task Force...
BACKGROUND. Anal cancer is an uncommon malignancy in the US; up to 93% of anal cancers are associated with human papillomavirus. METHODS. Cases diagnosed between 1998 and 2003 from 39 population-based registries were analyzed. The following histologies included analysis: squamous cell, adenocarcinoma, small cell/neuroendocrine carcinomas. Incidence rates age-adjusted 2000 US standard population. RESULTS. From through 2003, annual invasive incidence rate was 1.5 per 100,000 persons. Squamous...
BACKGROUND In the first CONCORD study (2008), 5‐year survival for patients diagnosed with colon cancer between 1990 and 1994 in United States was among highest world (60%), but there were large racial disparities most participating states. The CONCORD‐2 (2015) enabled examination of trends 1995 2009 US states by race stage. METHODS authors analyzed data from 37 state population‐based registries, covering approximately 80% population, who 2001 followed through 2009. Survival up to 5 years...
Annual testing using either a high-sensitivity guaiac fecal occult blood test (HS-gFOBT) or immunochemical (FIT) is recommended for screening average-risk people colorectal cancer. We compared the performance characteristics of HS-gFOBT Hemoccult II SENSA and two FITs (InSure FIT OC FIT-CHEK) detecting advanced neoplasia.The study included 1,006 asymptomatic patients, aged 50-75 years, who were scheduled to receive colonoscopy at gastroenterology practices in Minneapolis Indianapolis...
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Prevention and Health Promotion. PCD provides an open exchange of information knowledge among researchers, practitioners, policy makers, others who strive to improve health public through chronic disease prevention.
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Prevention and Health Promotion. PCD provides an open exchange of information knowledge among researchers, practitioners, policy makers, others who strive to improve health public through chronic disease prevention.
Community health centers are uniquely positioned to address disparities in colorectal cancer (CRC) screening as they have addressed other disparities. In 2012, the federal Health Resources and Services Administration, which is funding agency for center program, added a requirement that report CRC rates standard performance measure. These annually reported, publically available data major strategic opportunity improve CRC. The Patient Protection Affordable Care Act enacted provisions expand...
Colorectal cancer (CRC) is the second leading cause of death among cancers that affect both men and women. Despite strong evidence their effectiveness, CRC screening tests are underused. Racial/ethnic minority groups, persons without insurance, those with lower educational attainment, household income levels have rates screening. Since 2009, CDC's Cancer Control Program (CRCCP) has supported state health departments tribal organizations in implementing evidence-based interventions (EBIs) to...
BACKGROUND In the first CONCORD study, 5‐year survival for patients with diagnosed rectal cancer between 1990 and 1994 was <60%, large racial disparities noted in majority of participating states. We have updated these findings to 2009 by examining population‐based stage disease at time diagnosis, race, calendar period. METHODS Data from CONCORD‐2 study were used compare among individuals aged 15 99 years who 37 states encompassing up 80% US population. estimated net 5 after diagnosis...
The US Preventive Services Task Force (USPSTF) recommends select preventive clinical services, including cancer screening. However, screening for cancers remains underutilized in the United States. Centers Disease Control and Prevention leads initiatives to increase breast, cervical, colorectal (CRC) We assessed number of avoidable deaths from increased screening, according USPSTF recommendations, CRC female breast cervical cancers.We used model-based estimates lifetime single-year age...
BACKGROUND Colorectal cancer remains the second leading cause of cancer‐related deaths among US men and women. Screening rates have been slow to increase, disparities in screening remain. METHODS To address disparity for this high burden but largely preventable disease, Centers Disease Control Prevention (CDC) designed established a 4‐year Cancer Demonstration Program (CRCSDP) 2005 low‐income, under‐insured or uninsured women aged 50 64 years 5 participating program sites. In report, authors...
There are scant data available on the relationship between smoking and total prostate specific antigen, free antigen percent-free antigen. Given high prevalence of frequency screening, it is important to determine any association values using nationally representative data.Included in final study population were 3,820 men 40 years old or older who participated 2001-2006 NHANES (National Health Nutrition Examination Survey) met eligibility criteria for testing. The distributions total,...
For the last 22 years, Centers for Disease Control and Prevention (CDC) National Breast Cervical Cancer Early Detection Program (NBCCEDP) has provided high quality breast cervical cancer screening to women who do not have health insurance or inadequate insurance. As care landscape changes, it is time CDC address new identified needs opportunities increase further explore expanded roles program looking future. The NBCCEDP well positioned build upon its experience, established clinical...